Article

SARS-CoV-2 Delta derivatives impact on neutralization of Covishield recipient sera

2021-12-02

Abstract excerpt

The emergence of SARS-CoV-2 Delta variant and its derivatives has created grave public health problem worldwide. The high transmissibility associated with this variant has led to daily increase in the number of SARS-CoV-2 infections. Delta variant has slowly dominated the other variants of concern. Subsequently, Delta has further mutated to Delta AY.1 to Delta AY.126. Of these, Delta AY.1 has been reported from se...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3a26230a-602f-5905-9ff0-042665eac307
DOI: 10.1101/2021.11.30.470521

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 Delta derivatives impact on neutralization of Covishield recipient seraDOI 10.1101/2021.11.30.470521Read

Neutralization of Delta variant with sera of Covishield vaccinees and COVID-19 recovered vaccinated individualsSemantic proximity Read

Current Review of Delta Variant of SARS-CoV-2Semantic proximity Read

Comparable neutralization of SARS-CoV-2 Delta AY.1 and Delta in individuals sera vaccinated with BBV152Semantic proximity Read

Ad26.COV2.S elicited neutralizing activity against Delta and other SARS-CoV-2 variants of concernSemantic proximity Read

Variants of SARS-CoV-2, their effects on infection, transmission and neutralization by vaccine-induced antibodies.Semantic proximity Read

Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccinationSemantic proximity Read

Vaccine efficacy in mutant SARS-CoV-2 variants.Semantic proximity Read

Neutralization potential of Covishield vaccinated individuals sera against B.1.617.1Semantic proximity Read

The Lambda variant of SARS-CoV-2 has a better chance than the Delta variant to escape vaccinesSemantic proximity Read

SARS CoV-2 escape variants exhibit differential infectivity and neutralization sensitivity to convalescent or post-vaccination seraSemantic proximity Read

Genomic analysis of SARS-CoV-2 breakthrough infections from Varanasi, IndiaSemantic proximity Read

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasionSemantic proximity Read